KR20230062278A - Novel strain of Lacrimispora algidixylanolytica producing carbohydrase and use thereof - Google Patents
Novel strain of Lacrimispora algidixylanolytica producing carbohydrase and use thereof Download PDFInfo
- Publication number
- KR20230062278A KR20230062278A KR1020210147370A KR20210147370A KR20230062278A KR 20230062278 A KR20230062278 A KR 20230062278A KR 1020210147370 A KR1020210147370 A KR 1020210147370A KR 20210147370 A KR20210147370 A KR 20210147370A KR 20230062278 A KR20230062278 A KR 20230062278A
- Authority
- KR
- South Korea
- Prior art keywords
- strain
- algidixylanolytica
- lacrimispora
- present
- carbohydrate
- Prior art date
Links
- 108010089934 carbohydrase Proteins 0.000 title description 2
- 102000004190 Enzymes Human genes 0.000 claims abstract description 47
- 108090000790 Enzymes Proteins 0.000 claims abstract description 47
- 229940088598 enzyme Drugs 0.000 claims abstract description 47
- 239000000203 mixture Substances 0.000 claims abstract description 32
- 241000283690 Bos taurus Species 0.000 claims abstract description 23
- 239000003674 animal food additive Substances 0.000 claims abstract description 22
- 108010059892 Cellulase Proteins 0.000 claims abstract description 21
- 108010055059 beta-Mannosidase Proteins 0.000 claims abstract description 19
- 229940106157 cellulase Drugs 0.000 claims abstract description 19
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 239000004382 Amylase Substances 0.000 claims abstract description 11
- 108010065511 Amylases Proteins 0.000 claims abstract description 11
- 102000013142 Amylases Human genes 0.000 claims abstract description 11
- 235000019418 amylase Nutrition 0.000 claims abstract description 11
- 150000001720 carbohydrates Chemical class 0.000 claims description 49
- 235000014633 carbohydrates Nutrition 0.000 claims description 49
- 230000000694 effects Effects 0.000 claims description 43
- 239000013592 cell lysate Substances 0.000 claims description 27
- 239000001963 growth medium Substances 0.000 claims description 16
- 238000000354 decomposition reaction Methods 0.000 claims description 15
- 244000005700 microbiome Species 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 11
- 239000006143 cell culture medium Substances 0.000 claims description 11
- 230000000593 degrading effect Effects 0.000 claims description 11
- 108020004465 16S ribosomal RNA Proteins 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 229920002488 Hemicellulose Polymers 0.000 claims description 4
- 210000002249 digestive system Anatomy 0.000 claims description 3
- 235000013305 food Nutrition 0.000 abstract description 17
- 230000000813 microbial effect Effects 0.000 abstract description 17
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 5
- 239000000243 solution Substances 0.000 description 23
- 239000000758 substrate Substances 0.000 description 22
- 239000002609 medium Substances 0.000 description 19
- 235000013376 functional food Nutrition 0.000 description 18
- 230000036541 health Effects 0.000 description 17
- 238000009472 formulation Methods 0.000 description 13
- 230000015556 catabolic process Effects 0.000 description 12
- 238000006731 degradation reaction Methods 0.000 description 12
- 239000006150 trypticase soy agar Substances 0.000 description 12
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 11
- 229920002472 Starch Polymers 0.000 description 11
- 239000008107 starch Substances 0.000 description 11
- 235000019698 starch Nutrition 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 9
- 235000012054 meals Nutrition 0.000 description 9
- 239000000843 powder Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 240000007594 Oryza sativa Species 0.000 description 7
- 235000007164 Oryza sativa Nutrition 0.000 description 7
- 238000012258 culturing Methods 0.000 description 7
- 238000012818 gel-diffusion assay Methods 0.000 description 7
- 244000144972 livestock Species 0.000 description 7
- 235000009566 rice Nutrition 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- 235000010980 cellulose Nutrition 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 102000042567 non-coding RNA Human genes 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000010902 straw Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 229920000057 Mannan Polymers 0.000 description 4
- 241000360105 [Clostridium] algidixylanolyticum Species 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 244000060011 Cocos nucifera Species 0.000 description 3
- 235000013162 Cocos nucifera Nutrition 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920000161 Locust bean gum Polymers 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000012669 liquid formulation Substances 0.000 description 3
- 239000000711 locust bean gum Substances 0.000 description 3
- 235000010420 locust bean gum Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000007447 staining method Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000237369 Helix pomatia Species 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000011146 sterile filtration Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- -1 β-mannase Proteins 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000186528 Clostridium tertium Species 0.000 description 1
- 241000737241 Cocos Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102100022087 Granzyme M Human genes 0.000 description 1
- 108050003624 Granzyme M Proteins 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 241000186610 Lactobacillus sp. Species 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000001164 bioregulatory effect Effects 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 230000002554 disease preventive effect Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 238000012817 gel-diffusion technique Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000001974 tryptic soy broth Substances 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/2488—Mannanases
- C12N9/2491—Beta-mannosidase (3.2.1.25), i.e. mannanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Birds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
본 발명은 탄수화물 분해효소를 생산하는 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 및 이의 용도에 관한 것으로, 보다 상세하게는 β-만나아제 (β-mannanase), 아밀라아제 (amylase) 및 셀룰라아제 (cellulase)와 같은 탄수화물 분해효소를 생산 및 분비하는, 소의 소화기관 유래 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주 (기탁번호 KCTC14734BP) 및 이의 탄수화물 분해효소 생산능을 이용한 미생물 제제, 사료 첨가제 및 식품 조성물 등을 제공한다.The present invention relates to Lacrimispora algidixylanolytica and its use, which produce carbohydrate digesting enzymes, and more specifically to β-mannanase, amylase and cellulase ( cellulase), which produces and secretes carbohydrate-degrading enzymes, derived from the digestive system of cattle, Lacrimispora algidixylanolytica strain (Accession No. KCTC14734BP) and microbial preparations and feed additives using the ability to produce carbohydrate-degrading enzymes and food compositions.
난소화성 탄수화물은 영양적 가치가 떨어지며, 반추동물에서도 사료로서의 효율성이 떨어지고 물리적으로도 이물감을 준다. 따라서 농축부산물에 존재하는 난소화성 탄수화물의 분해는 사료로서의 가치를 매우 높일 수 있다. 예를 들어, 소의 경우 볏짚을 직접 소화하는 것이 아니고 위에 존재하는 미생물의 도움으로 소화를 하는데, 이와 같은 작용을 볏짚에 적용하여 미생물로 볏짚에 함유된 셀룰로스를 당화시킴으로써 사료 가치를 높일 수 있다. 난소화성 탄수화물인 셀룰로스를 당화시키기 위해서는 셀룰라아제 (cellulase) 같은 효소가 필요하며, 효소 자체로 당화를 하기에는 실용화에 어려움이 많으므로 효소를 제공해 줄 미생물이 필요하다.Indigestible carbohydrates have low nutritional value and are less effective as feed for ruminants and give a physically foreign feeling. Therefore, decomposition of indigestible carbohydrates present in agricultural by-products can greatly increase the value as feed. For example, in the case of cattle, rice straw is not digested directly, but digested with the help of microorganisms present in the stomach. By applying this action to rice straw, the microorganisms can saccharify the cellulose contained in rice straw, thereby increasing the feed value. In order to saccharify cellulose, which is an indigestible carbohydrate, an enzyme such as cellulase is required, and since it is difficult to saccharify with the enzyme itself, it is difficult to put it into practical use, so a microorganism to provide the enzyme is needed.
또 다른 사료 원료로, 고함량의 섬유질을 함유하고 있는 팜 종자박은 만난(mannan)을 주성분으로하는 섬유질로 구성되어 있어서 소화가 어렵고, 대사 에너지가 상대적으로 낮다. 팜 종자박에 있는 섬유질은 주로 만난 타입의 헤미셀룰로오스(Daud and Jarvis, Phytochemistry, 31(2): 463-464, 1992)이므로 만난분해효소인 만나아제를 처리할 경우 소화성이 증진될 수 있다. 팜 종자박의 만난 섬유질은 가수분해 되면 만노스(mannose)를 비롯하여 단위동물에 의하여 소화흡수될 수 있는 다양한 소화성 당들이 생성된다(Dusterhoft et al., Bioresource Technology, 44, 39-46, 1993; Daud et al., Proc. of the 19th Malaysian society of animal Production Annual Conference. 8-10 september 1997, Johor Bahru, Johor, Malaysia). 코프라 박(copra meal)은 상기의 팜 종자박과 같은 야자과(Arecaceae) 식물인 코코스야자의 배젖(copra)으로부터 오일 채유 후 잔존하는 분말로서, 팜 종자박과 같이 만난을 주성분으로 하는 섬유질로 구성되어 있어 단위동물용 사료로는 적합하지 못하다.As another feed material, palm seed meal containing high fiber content is composed of mannan-based fiber, which is difficult to digest and has relatively low metabolic energy. Since the fiber in palm seed meal is mainly mannan-type hemicellulose (Daud and Jarvis, Phytochemistry, 31 (2): 463-464, 1992), the digestibility can be improved when mannanase, a mannan degrading enzyme, is treated. Mannan fiber of palm seed meal is hydrolyzed to produce various digestible sugars including mannose that can be digested and absorbed by unit animals (Dusterhoft et al., Bioresource Technology, 44, 39-46, 1993; Daud et al. al., Proc. of the 19th Malaysian society of animal Production Annual Conference.8-10 september 1997, Johor Bahru, Johor, Malaysia). Copra meal is a powder remaining after oil extraction from the copra of a cocos palm, a plant of the Arecaceae family, such as the palm seed meal, and is composed of fibers mainly composed of mannan, such as palm seed meal. Therefore, it is not suitable for unit animal feed.
통상적으로 β-만나아제는 바실러스 (Bacillus)와 같은 세균, 아스퍼질러스 (Aspergillus)와 같은 곰팡이 및 고등식물에서 분리되고 있다. 일본등록특허 JP5176767호는 클로스트리디움 터티움 (Clostridium tertium)과 락토바실러스 (Lactobacillus sp.)를 혐기적으로 배양하여 식품용 β-1,4-만나아제를 생산하는 방법을 개시하였다.Conventionally, β-mannanase has been isolated from bacteria such as Bacillus , fungi such as Aspergillus , and higher plants. Japanese Patent Registration No. JP5176767 discloses a method for producing β-1,4-mannase for food by anaerobically culturing Clostridium tertium and Lactobacillus sp.
이러한 배경 하에, 본 발명자들은 난소화성 탄수화물을 주성분으로 하는 볏짚, 팜 종자박 또는 코프라 박과 같은 사료 원료의 가치를 증진시키고, 농축부산물의 사료 자원화로 곡류 사료 대체 및 경쟁력을 확보하고자, 난소화성 탄수화물 분해효소를 생산 및/또는 분비하는 균주를 한우의 장내 미생물로부터 분리 및 동정하고, 이를 가축용 사료 첨가제, 건강기능식품 등으로 활용하고자 하였다.Under this background, the present inventors improved the value of feed raw materials such as rice straw, palm seed meal, or copra meal, which have indigestible carbohydrates as the main component, and in order to secure grain feed substitution and competitiveness by using agricultural and livestock by-products as feed resources, indigestible carbohydrates Strains producing and/or secreting decomposing enzymes were isolated and identified from intestinal microorganisms of Korean cattle, and were intended to be used as livestock feed additives and health functional foods.
본 발명은 상술한 과제를 해결하기 위해 안출된 것으로, 탄수화물 분해효소를 생산 및/또는 분비하는 균주, 이를 포함하는 미생물 제제, 사료 첨가제 및 건강기능식품을 제공하는 것을 목적으로 한다.The present invention has been made to solve the above problems, the object of the present invention is to provide strains that produce and / or secrete carbohydrate decomposing enzymes, microbial preparations, feed additives and health functional foods containing the same.
상술한 과제를 해결하기 위해, 본 발명은 기탁번호 KCTC14734BP로 기탁된, 탄수화물 분해효소를 생산하는 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주를 제공한다.In order to solve the above problems, the present invention provides a Lacrimispora algidixylanolytica strain deposited under accession number KCTC14734BP and producing a carbohydrate decomposing enzyme.
추가로, 본 발명은 상기 탄수화물 분해효소를 생산하는 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주 (기탁번호 KCTC14734BP), 이의 배양액 또는 상기 균주 및 이의 배양액을 유효성분으로 포함하는, 미생물 제제를 제공한다.Additionally, the present invention is a Lacrimispora algidixylanolytica strain (Accession No. KCTC14734BP), a culture solution thereof or a microbial preparation comprising the strain and its culture solution as active ingredients, which produce the carbohydrate degrading enzyme. provides
나아가, 본 발명은 상기 탄수화물 분해효소를 생산하는 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주 (기탁번호 KCTC14734BP), 이의 배양액 또는 상기 균주 및 이의 배양액을 유효성분으로 포함하는, 사료 첨가제를 제공한다.Furthermore, the present invention provides a feed additive comprising a Lacrimispora algidixylanolytica strain (Accession No. KCTC14734BP), a culture thereof, or the strain and its culture medium as active ingredients, which produce the carbohydrate decomposing enzyme. to provide.
본 발명의 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주 (기탁번호 KCTC14734BP)는 β-만나아제, 아밀라아제 및 셀룰라아제와 같은 다양한 탄수화물 분해효소를 생산 및 분비하므로, 이를 난소화성 탄수화물 처리 기술 개발 및 볏짚과 같은 농축부산물의 사료 자원화로 곡류 사료를 대체하여 부가가치 상승을 기대할 수 있다.Since the Lacrimispora algidixylanolytica strain (Accession No. KCTC14734BP) of the present invention produces and secretes various carbohydrate digesting enzymes such as β-mannase, amylase and cellulase, it develops indigestible carbohydrate processing technology. And by using agricultural and livestock by-products such as rice straw as feed resources, an increase in added value can be expected by substituting grain feed.
도 1은 β-만나아제 효소 생산 후보 균주의 발굴을 위해 상업적으로 판매되는 β-만나아제 및 이의 기질인 로스트 빈 검 (Lost bean gum, LBG)을 이용하여 겔 확산 검정 분석 조건을 확립한 결과를 나타낸 것이다.
도 2는 β-만나아제 효소 생산 후보 균주의 세포 용해물 (cell lysate)의 탄수화물 기질 4종 (전분, CM-셀룰로오스, X-gal 및 LGB) 각각에 대한 분해 활성을 겔 확산 검정 (Gel diffusion assay) 분석으로 확인한 결과를 나타낸 것이다.
도 3은 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica)로 확인된 균주 생균의 탄수화물 기질 4종 (전분, CM-셀룰로오스, X-gal 및 LGB) 각각에 대한 분해 활성을 겔 확산 검정 분석으로 확인한 결과를 나타낸 것이다.
도 4는 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica)로 확인된 균주 배양액의 탄수화물 기질 4종 (전분, CM-셀룰로오스, X-gal 및 LGB) 각각에 대한 분해 활성을 겔 확산 검정 분석으로 확인한 결과를 나타낸 것이다.Figure 1 shows the results of establishing gel diffusion assay conditions using commercially sold β-mannanase and its substrate, Lost bean gum (LBG), for the discovery of candidate strains for producing β-mannanase enzymes. it is shown
Figure 2 shows the degradation activity for each of the four carbohydrate substrates (starch, CM-cellulose, X-gal and LGB) of the cell lysate (cell lysate) of the β-mannase enzyme production candidate strain (Gel diffusion assay) ) shows the results confirmed by the analysis.
Figure 3 shows the degradation activity for each of the four carbohydrate substrates (starch, CM-cellulose, X-gal and LGB) of the live cell strain identified as Lacrimispora algidixylanolytica by gel diffusion assay analysis. It shows the confirmed result.
Figure 4 shows the degradation activity for each of the four carbohydrate substrates (starch, CM-cellulose, X-gal and LGB) of the strain culture broth identified as Lacrimispora algidixylanolytica by gel diffusion assay analysis. It shows the confirmed result.
상술한 바와 같이, 본 발명자들은 난소화성 탄수화물을 주성분으로 하는 농축산부산물의 사료 가치를 증진시키고, 이들을 사료 자원화함으로써 곡류 사료 대체 및 경쟁력을 확보하기 위한 수단으로, 난소화성 탄수화물 분해효소를 생산 및/또는 분비하는 미생물을 발굴하고자 예의 노력한 결과, 소의 장내 유래 미생물 중 β-만나아제 (β-mannanase), 아밀라아제 (amylase) 및 셀룰라아제 (cellulase)와 같은 탄수화물 분해효소를 생성 및/또는 분비하는 균주를 분리하였고, 16S RNA 유전자 분석을 통해 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica)임을 확인하여, 한국생명공학연구원 생물자원센터 (KCTC: Korean Collection for Type Cultures)에 기탁하였다 (기탁번호 KCTC14734BP).As described above, the inventors of the present invention improve the feed value of agricultural and livestock by-products containing indigestible carbohydrates as a main component, and produce and/or As a result of diligent efforts to discover secreting microorganisms, strains that produce and/or secrete carbohydrate degrading enzymes such as β-mannanase, amylase, and cellulase were isolated from the microorganisms derived from the intestine of cattle. , Lacrimispora algidixylanolytica was confirmed through 16S RNA gene analysis and deposited at the Korea Research Institute of Bioscience and Biotechnology (KCTC: Korean Collection for Type Cultures) (Accession No. KCTC14734BP).
본 발명의 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주 (기탁번호 KCTC14734BP)는 β-만나아제, 아밀라아제 및 셀룰라아제와 같은 다양한 탄수화물 분해효소를 생산 및 분비하므로, 난소화성 탄수화물의 분해 활성을 증진시키기 위한 목적으로 사료 또는 식품에 첨가될 수 있고, 다양한 건강기능성 식품으로 활용가능하다.Since the Lacrimispora algidixylanolytica strain (Accession No. KCTC14734BP) of the present invention produces and secretes various carbohydrate degrading enzymes such as β-mannase, amylase and cellulase, it has a degrading activity of indigestible carbohydrates. It can be added to feed or food for the purpose of enhancing it, and it can be used as a variety of health functional foods.
따라서, 본 발명의 제1 측면은 기탁번호 KCTC14734BP로 기탁된, 탄수화물 분해효소를 생산하는 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주에 관한 것이다.Accordingly, the first aspect of the present invention relates to a Lacrimispora algidixylanolytica strain that produces a carbohydrate digesting enzyme deposited under Accession No. KCTC14734BP.
본 발명의 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주 (기탁번호 KCTC14734BP)는 소의 소화기관, 특히 장내에서 유래된 것이다. The Lacrimispora algidixylanolytica strain (Accession No. KCTC14734BP) of the present invention is derived from the digestive system of cattle, particularly the intestine.
상기 탄수화물 분해효소는 β-만나아제 (β-mannanase), 아밀라아제 (amylase) 및 셀룰라아제 (cellulase)로 이루어진 군으로부터 선택되는 어느 하나 이상일 수 있다.The carbohydrate decomposing enzyme may be any one or more selected from the group consisting of β-mannanase, amylase and cellulase.
본 발명의 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주 (기탁번호 KCTC14734BP)의 분리 및 동정 방법은 다음과 같다.The isolation and identification method of the Lacrimispora algidixylanolytica strain (Accession No. KCTC14734BP) of the present invention is as follows.
먼저, 소의 분변에서 채취한 시료를 적절히 희석한 후, 이를 배지에 도말하고, 배양시켜 콜로니를 형성시킨 후, 미생물 균주를 분리하고 이의 세포 용해물을 제조하였다. 그런 다음, 로커스트 빈 검 기질(Locust bean gum)을 이용하여 상업 효소 β-만나아제 활성 분석 조건을 도 1과 같이 확립하고, 100종 이상의 소 장내 유래 미생물 세포 용해물로부터 β-만나아제 활성 후보 균주 1종을 표 1과 같이 발굴하였다.First, after properly diluting a sample taken from cow feces, it was smeared on a medium and cultured to form a colony, and then a microbial strain was isolated and a cell lysate thereof was prepared. Then, commercial enzyme β-mannanase activity assay conditions were established as shown in FIG. 1 using Locust bean gum substrate, and β-mannanase activity candidate strains from more than 100 small intestine-derived microbial cell lysates One species was excavated as shown in Table 1.
이때, 상기 배지로는 LBG 평판배지, 트립틱 소이(Tryptic soy) 평판배지, 뉴트리언트(Nutrient) 평판배지, 루리아-버타니(Luria-bertani) 평판배지 등을 사용할 수 있으며, 활성을 확인하고자 하는 효소의 종류에 따라 효소의 기질을 유일한 탄소원으로 첨가하여 해당 효소의 활성을 평가할 수 있다.At this time, as the medium, LBG plate medium, Tryptic soy plate medium, Nutrient plate medium, Luria-bertani plate medium, etc. may be used, and Depending on the type of enzyme, the enzyme's substrate can be added as the only carbon source to evaluate the activity of the enzyme.
본 발명의 구체적인 일 실시예에서는 후보 균주의 탄수화물 분해 활성을 확인하기 위해, 이의 세포 용해물을 이용하여, 4종의 탄수화물 기질 (전분, CM-셀룰로오스, X-gal 및 LBG)에 대한 분해 활성을 겔 확산 검정 방법에 따라 확인하였다. 그 결과, 도 2에서 확인되는 바와 같이 셀룰라아제 효소의 기질인 카르복실메틸셀룰로오스 (CM-셀룰로오스)와 β-만나아제 (β-mannanase) 효소의 기질인 로커스트 빈 검 분해에 의해 투명해진 분해환이 형성되어, 후보 균주는 셀룰라아제와 β-만나아제 효소 활성을 보유하는 것으로 나타났다.In a specific embodiment of the present invention, in order to confirm the carbohydrate degradation activity of the candidate strain, using its cell lysate, the degradation activity for four carbohydrate substrates (starch, CM-cellulose, X-gal and LBG) It was confirmed according to the gel diffusion assay method. As a result, as shown in FIG. 2, a transparent decomposition ring was formed by decomposition of carboxylmethylcellulose (CM-cellulose), which is a substrate of cellulase enzyme, and locust bean gum, which is a substrate of β-mannanase enzyme. , the candidate strain was shown to possess cellulase and β-mannase enzyme activities.
상기 셀룰라아제 및 β-만나아제 효소 활성을 보유하는 것으로 확인된 후보 균주는, 16S RNA 유전자 분석 결과, 표 2에서 확인되는 바와 같이 16S RNA 유전자 서열이 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica, 이명: 클로스트리듐 알지딕실라놀리티카 (Clostridium algidixylanolyticum))와 100% 상동성을 나타내어, 최종적으로 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica, 이명: 클로스트리듐 알지딕실라놀리티카 (Clostridium algidixylanolyticum))로 동정되었다.Candidate strains confirmed to have the cellulase and β-mannase enzyme activities are 16S RNA gene analysis results, as shown in Table 2, the 16S RNA gene sequence is Lacrimispora algidixylanolytica , Synonym: Clostridium algidixylanolyticum ) and 100% homology, finally Lacrimispora algidixylanolytica (Synonym: Clostridium algidixylanolyticum) algidixylanolyticum )).
본 발명의 구체적인 일 실시예에서는, 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica)로 동정된 균주의 생균 및 배양액을 이용하여, 4종의 탄수화물 기질 (전분, CM-셀룰로오스, X-gal 및 LBG)에 대한 분해 활성을 겔 확산 검정 방법에 따라 추가로 확인하였다. 그 결과, 도 3 및 4에서 확인되는 바와 같이 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica)로 동정된 균주의 생균 및 이의 배양액은 아밀라아제, 셀룰라아제 및 β-만나아제 효소들을 생산하며, 배양액 실험 결과를 바탕으로 하였을 때, 해당 효소들은 모두 세포외 유형인 것으로 추정된다.In a specific embodiment of the present invention, four carbohydrate substrates (starch, CM- cellulose , X-gal and LBG) was further confirmed according to the gel diffusion assay method. As a result, as shown in FIGS. 3 and 4, the live cells of the strain identified as Lacrimispora algidixylanolytica and their culture medium produce amylase, cellulase and β-mannase enzymes, and culture medium experiments Based on the results, it is assumed that the enzymes are all of the extracellular type.
따라서, 본 발명의 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica)로 동정된 균주는 셀룰라아제 및 β-만나아제 효소 활성을 보유하며, 동시에 아밀라아제, 셀룰라아제 및 β-만나아제 효소 생산능 및 분비능을 갖는다. 이러한 탄수화물 분해효소는 난소화성 탄수화물 분해효소이므로, 본 발명의 균주는 난소화성 탄수화물의 분해 활성을 증진시키기 위한 목적으로 미생물 제제로서 사료 또는 식품에 첨가될 수 있고, 다양한 건강기능성 식품으로 활용가능하다.Therefore, the strain identified as Lacrimispora algidixylanolytica of the present invention has cellulase and β-mannase enzyme activities, and at the same time has amylase, cellulase and β-mannase enzyme production and secretion capabilities have Since these carbohydrate decomposing enzymes are indigestible carbohydrate degrading enzymes, the strain of the present invention can be added to feed or food as a microbial preparation for the purpose of enhancing the decomposition activity of indigestible carbohydrates, and can be utilized as various health functional foods.
따라서, 본 발명의 제2 측면은 전술한 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주 (기탁번호 KCTC14734BP), 이의 세포 용해물, 배양액 또는 상기 이들의 혼합물을 유효성분으로 포함하는 미생물 제제 및 이의 용도에 관한 것이다.Accordingly, the second aspect of the present invention is a microbial preparation comprising the above-described Lacrimispora algidixylanolytica strain (Accession No. KCTC14734BP), a cell lysate thereof, a culture medium, or a mixture thereof as an active ingredient. and uses thereof.
본 발명에서, 용어 "세포 용해물"은 본 발명에 따른 상기 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주를 bead ruptor를 이용한 파쇄와 같은 물리적인 방법으로 단순히 터트려 추출하여 얻은 세포 내에 존재하는 모든 수용성 구성물질을 통칭하는 것을 의미한다.In the present invention, the term "cell lysate" is present in cells obtained by simply bursting and extracting the Lacrimispora algidixylanolytica strain according to the present invention by a physical method such as disruption using a bead ruptor It means collectively all water-soluble constituents that
본 발명에서 용어 "배양액"은 "배양 상층액", "조건 배양액" 또는 "조정 배지"와 호환적으로 사용될 수 있고, 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica)가 시험관 내에서 성장 및 생존할 수 있도록 영양분을 공급할 수 있는 배지에 상기 균주를 일정기간 배양하여 얻는 상기 균주, 이의 대사물, 여분의 영양분 등을 포함하는 전체 배지를 의미할 수 있다. 또한, 상기 배양액은 균주를 배양하여 얻은 균체 배양액에서 균체를 제거한 배양액을 의미할 수도 있다. 한편, 상기 배양액 중 균체를 제거한 액체를 "상등액"이라고도 하며, 배양액을 일정시간 가만히 두어 하층에 가라앉은 부분을 제외한 상층의 액체만을 취하거나, 여과를 통해 균체를 제거하거나, 배양액을 원심분리하여 하부의 침전을 제거하고 상부의 액체만을 취하여 획득할 수 있다. 상기 "균체"는 본 발명의 균주 자체를 의미하는 것으로 소의 분변으로부터 분리하여 선별한 균주 자체 또는 상기 균주를 배양하여 배양액으로부터 분리한 균주를 포함한다. 상기 균체는 배양액을 원심분리하여 하층에 가라앉은 부분을 취하여 획득할 수 있고, 또는 중력에 의해 배양액의 하층으로 가라앉으므로 일정 시간동안 가만히 두었다가 상부의 액체를 제거함으로써 획득할 수 있다.In the present invention, the term "culture medium" can be used interchangeably with "culture supernatant", "conditional culture medium" or "conditioned medium", and Lacrimispora algidixylanolytica is grown and It may mean the entire medium including the strain obtained by culturing the strain for a certain period of time in a medium capable of supplying nutrients to survive, metabolites thereof, and extra nutrients. In addition, the culture solution may mean a culture solution obtained by removing the cells from the cell culture solution obtained by culturing the strain. On the other hand, the liquid from which the cells are removed from the culture solution is also called "supernatant", and the culture solution is left still for a certain period of time to take only the liquid of the upper layer except for the part sunk in the lower layer, remove the cells through filtration, or centrifuge the culture solution to It can be obtained by removing the precipitate and taking only the upper liquid. The "cell" refers to the strain itself of the present invention, and includes the strain itself isolated and selected from cow feces or the strain isolated from the culture medium by culturing the strain. The cells can be obtained by centrifuging the culture solution and taking the part that has sunk to the lower layer, or it can be obtained by leaving it for a certain period of time and then removing the upper liquid because it sinks to the lower layer of the culture medium by gravity.
상기 배양액은 균주를 배양하여 수득된 배양액 자체, 그의 농축물, 또는 동결건조물 또는 배양액로부터 균주를 제거하여 수득된 배양 상층액, 그의 농축물 또는 동결건조물을 포함할 수 있다.The culture solution may include a culture solution itself obtained by culturing the strain, a concentrate thereof, or a lyophilized product or a culture supernatant obtained by removing the strain from the culture solution, a concentrate thereof, or a lyophilisate.
본 발명에 따른 미생물 제제는 용액, 분말, 현탁액, 분산액, 에멀젼, 유성 분산액, 페이스트, 분진, 흩뿌림 물질 또는 과립제 형태로 제조되어 사료, 식품 또는 건강기능식품 등에 다양하게 적용될 수 있다.Microbial preparations according to the present invention are prepared in the form of solutions, powders, suspensions, dispersions, emulsions, oily dispersions, pastes, dusts, scattering materials, or granules, and can be variously applied to feeds, foods, or health functional foods.
구체적으로, 본 발명에 따른 상기 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주는 난소화성 탄수화물의 분해 활성을 증진시키기 위한 목적으로 사료에 첨가될 수 있다.Specifically, the Lacrimispora algidixylanolytica strain according to the present invention may be added to feed for the purpose of enhancing the decomposition activity of indigestible carbohydrates.
따라서, 본 발명은 상기 균주, 이의 세포 용해물, 배양액 또는 이들의 혼합물을 유효성분으로 포함하는 사료 첨가제를 제공한다.Therefore, the present invention provides a feed additive comprising the strain, its cell lysate, culture medium or a mixture thereof as an active ingredient.
본 발명에 따른 사료 첨가제는 구연산, 후말산, 아디픽산, 젖산 및 사과산 등과 같은 유기산; 인산나트륨, 인산칼륨, 산성피로인산염, 폴리인산염(중합인산염)등과 같은 인산염; 폴리페놀, 카테킨(catechin), 알파-토코페롤, 로즈메리 추출물(rosemary extract), 비타민 C, 녹차 추출물, 감초 추출물, 키토산, 탄닌산, 피틴산 등과 같은 천연 항산화제;로부터 선택되는 하나 이상을 더 포함할 수 있다.Feed additives according to the present invention include organic acids such as citric acid, fumaric acid, adipic acid, lactic acid and malic acid; phosphates such as sodium phosphate, potassium phosphate, acid pyrophosphate, polyphosphate (polyphosphate) and the like; Natural antioxidants such as polyphenols, catechin, alpha-tocopherol, rosemary extract, vitamin C, green tea extract, licorice extract, chitosan, tannic acid, and phytic acid; there is.
본 발명에 따른 사료 첨가제는 아미노산, 무기염류, 비타민, 항생물질, 항균물질, 항산화, 항곰팡이 효소 및 다른 생균 형태의 미생물 제제 등과 같은 보조제 성분; 곡물, 예를 들어, 분쇄 또는 파쇄된 밀, 귀리, 보리, 옥수수 및 쌀; 식물성 단백질 사료, 예를 들어, 평지, 콩 및 해바라기를 주성분으로 하는 것; 동물성 단백질 사료, 예를 들어, 혈분, 육분, 골분 및 생선분; 당분 및 유제품, 예를 들어, 각종 분유 및 유장 분말로 이루어지는 건조성분; 지질, 예를 들어, 가열에 의해 임의로 액화시킨 동물성 지방 및 식물성 지방 등과 같은 주성분; 영양보충제, 소화 및 흡수향상제, 성장촉진제, 질병예방제 등과 같은 첨가제;로부터 선택되는 하나 이상을 더 포함할 수 있다.The feed additive according to the present invention may include auxiliary components such as amino acids, inorganic salts, vitamins, antibiotics, antimicrobial substances, antioxidants, antifungal enzymes and other live microbial preparations; grains such as ground or crushed wheat, oats, barley, corn and rice; vegetable protein feeds such as those based on rape, soybean and sunflower; animal protein feed such as blood meal, meat meal, bone meal and fish meal; dry ingredients consisting of sugar and dairy products, such as various powdered milk and whey powder; main components such as lipids, for example, animal fats and vegetable fats optionally liquefied by heating; It may further include one or more selected from additives such as nutritional supplements, digestion and absorption enhancers, growth promoters, and disease preventive agents.
본 발명에 따른 사료 첨가제는 건조 또는 액체 상태의 제제 형태일 수 있으며, 사료 첨가용 부형제를 포함할 수 있다. 상기 사료 첨가용 부형제로는 예를 들어, 제올라이트, 옥분 또는 미강 등이 있으나, 이로 한정되지 않는다.The feed additive according to the present invention may be in the form of a dry or liquid formulation, and may include an excipient for adding feed. Excipients for adding the feed include, for example, zeolite, jade powder or rice bran, but are not limited thereto.
본 발명에 따른 사료 첨가제는 동물에게 단독으로 투여되거나 식용 담체 중에서 다른 사료 첨가제와 조합되어 투여될 수 있다. 또한, 상기 사료 첨가제는 탑 드레싱으로서 또는 이들을 가축 사료에 직접 혼합하거나 또는 사료와 별도로, 별도의 경구 제형으로, 또는 다른 성분과 조합하여 쉽게 투여할 수 있다.The feed additive according to the present invention may be administered to animals alone or in combination with other feed additives in an edible carrier. In addition, the feed additives can be easily administered as a top dressing or directly mixed with livestock feed, separately from feed, in a separate oral formulation, or in combination with other ingredients.
본 발명이 속하는 기술분야에서 통상적으로 알려진 바와 같이 단독 일일 섭취량 또는 분할 일일 섭취량을 사용할 수 있다.A single daily intake or divided daily intake may be used, as is commonly known in the art to which the present invention pertains.
본 발명에 따른 사료 첨가제가 사용될 수 있는 동물은 예를 들어 식용우, 젖소, 송아지, 돼지, 양, 염소, 말, 토끼, 개, 고양이 등과 같은 가축, 병아리, 알닭, 가정용 닭, 수탉, 오리, 거위, 칠면조, 메추라기, 작은새 등과 같은 가금류를 포함하며, 특히, 소가 바람직하나, 이로 한정되지 않는다.Animals in which the feed additive according to the present invention can be used include, for example, livestock such as edible cattle, dairy cows, calves, pigs, sheep, goats, horses, rabbits, dogs, cats, chicks, chickens, domestic chickens, roosters, ducks, It includes poultry such as geese, turkeys, quails, small birds, etc., and in particular, cattle is preferred, but is not limited thereto.
본 발명에 따른 사료 첨가제에 포함되는 본 발명의 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주, 이의 세포 용해물, 배양액 또는 이들의 혼합물의 양은 특별히 한정되지 않으나, 본 발명이 속하는 기술분야에서 통상적으로 알려진 바와 같이 가축의 소화관에서 장기간 생존하면서 셀룰로오스 및/또는 헤미셀룰로오스와 같은 탄수화물을 분해하기에 적합한 양으로 포함된다.The amount of the Lacrimispora algidixylanolytica strain, its cell lysate, culture medium or a mixture thereof of the present invention included in the feed additive according to the present invention is not particularly limited, but the technical field to which the present invention belongs As is commonly known, it is included in an amount suitable for decomposing carbohydrates such as cellulose and/or hemicellulose while surviving for a long time in the digestive tract of livestock.
또한, 본 발명의 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) 균주는 난소화성 탄수화물의 분해 활성을 증진시키기 위한 목적으로 식품에 첨가될 수 있다.In addition, the Lacrimispora algidixylanolytica strain of the present invention may be added to food for the purpose of enhancing the decomposition activity of indigestible carbohydrates.
따라서, 본 발명은 상기 균주, 이의 세포 용해물, 배양액 또는 이들의 혼합물을 유효성분으로 포함하는 건강기능식품을 제공한다.Therefore, the present invention provides a health functional food containing the strain, its cell lysate, culture medium or a mixture thereof as an active ingredient.
본 발명에서 용어, "건강기능식품 (Health functional food 또는 nutraceutical)"은, 특정보건용 식품, 기능성 식품, 건강식품과 동일한 용어로, 양 공급 외에도 생체조절기능이 효율적으로 나타나도록 가공된 의학, 의료 효과가 높은 식품을 의미하는데, 상기 식품은 난소화성 탄수화물의 분해 활성 증진에 유용한 효과를 얻기 위해 저제, 캡슐, 분말, 과립, 액상, 환 등의 다양한 형태로 제조될 수 있다.In the present invention, the term "Health functional food (Health functional food or nutraceutical)" is the same term as specific health food, functional food, and health food, in addition to quantity supply, medicine and medical treatment that are processed to efficiently display bioregulatory functions. Means highly effective food, the food can be prepared in various forms such as pills, capsules, powders, granules, liquids, pills, etc. to obtain a useful effect in enhancing the decomposition activity of indigestible carbohydrates.
상기 건강기능식품은 식품학적으로 허용되는 담체를 포함할 수 있다.The health functional food may include a food-acceptable carrier.
본 출원에서 사용되는 용어, "식품적으로 허용 가능한 담체"란 균주를 자극하지 않으면서, 이의 생물학적 활성 및 특성을 저해하지 않는 담체 또는 희석제를 의미할 수 있다. As used herein, the term "food acceptable carrier" may refer to a carrier or diluent that does not inhibit the biological activity and properties of strains without stimulating them.
본 발명의 건강기능식품 조성물에서 사용 가능한 상기 담체의 종류는 특별히 제한되지 아니하며 당해 기술 분야에서 통상적으로 사용되고 식품학적으로 허용되는 담체라면 어느 것이든 사용할 수 있다. 상기 담체의 비제한적인 예로는, 식염수, 멸균수, 링거액, 완충 식염수, 알부민 주사 용액, 덱스트로즈 용액, 말토 덱스트린 용액, 글리세롤, 에탄올 등을 들 수 있다. 이들은 단독으로 사용되거나 2 종 이상을 혼합하여 사용될 수 있다.The type of carrier that can be used in the health functional food composition of the present invention is not particularly limited, and any carrier commonly used in the art and acceptable in food science can be used. Non-limiting examples of the carrier include saline, sterile water, Ringer's solution, buffered saline, albumin injection solution, dextrose solution, maltodextrin solution, glycerol, ethanol, and the like. These may be used alone or in combination of two or more.
본 발명의 건강기능식품은 당 업계에서 통상적으로 사용되는 방법에 의하여 제조가능하며, 상기 제조시에는 당 업계에서 통상적으로 첨가하는 원료 및 성분을 첨가하여 제조할 수 있다. 또한 상기 건강기능식품의 제형 또한 건강기능식품으로 인정되는 제형이면 제한 없이 제조될 수 있다. 본 발명의 건강기능식품은 다양한 형태의 제형으로 제조될 수 있으며, 일반 약품과는 달리 식품을 원료로 하여 약품의 장기 복용 시 발생할 수 있는 부작용 등이 없는 장점이 있다. The health functional food of the present invention can be prepared by a method commonly used in the art, and can be prepared by adding raw materials and components commonly added in the art during the preparation. In addition, the formulation of the health functional food may also be manufactured without limitation as long as the formulation is recognized as a health functional food. The health functional food of the present invention can be prepared in various types of formulations, and unlike general drugs, it has the advantage of using food as a raw material and not having side effects that may occur when taking the drug for a long time.
구체적으로, 상기 식품은 본 발명에 따른 균주를 음료, 차류, 향신료, 껌, 과자류 등의 식품소재에 첨가하거나, 캡 슐화, 분말화, 현탁액 등으로 제조한 식품으로, 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 건강 기능성 식품류 등으로 사용될 수 있다. Specifically, the food is a food prepared by adding the strain according to the present invention to food materials such as beverages, teas, spices, gum, confectionery, etc., or encapsulated, powdered, or suspended. For example, various foods, It can be used in beverages, gum, tea, vitamin complexes, and health functional foods.
상기 식품은 공지의 제조방법에 따라 정제, 과립, 분말, 캅셀, 액상의 용액 및 환 등의 제형으로 제조할 수 있으며, 본 발명에 따른 균주의 함량은 제형에 따라 조절할 수 있다. 본 발명에 따른 균주를 유효성분으로 포함하는 것 이외에 다른 성분에는 특별한 제한이 없으며, 통상의 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다.The food may be prepared in formulations such as tablets, granules, powders, capsules, liquid solutions and pills according to known manufacturing methods, and the content of the strain according to the present invention may be adjusted according to the formulation. There is no particular limitation on other ingredients other than including the strain according to the present invention as an active ingredient, and various common flavoring agents or natural carbohydrates may be included as additional ingredients.
본 발명에 따른 미생물 제제, 사료 첨가제 및 건강기능식품은 탄수화물 분해 활성 증진, 특히 난소화성 탄수화물 분해 증진 효능을 나타내며, 상기 난소화성 탄수화물은 셀룰로오스 및/또는 헤미셀룰로오스를 유효성분으로 포함하는 것이라면 제한없이 포함될 수 있다.Microbial preparations, feed additives, and health functional foods according to the present invention exhibit enhancement of carbohydrate decomposition activity, particularly, indigestible carbohydrate degradation enhancement efficacy, and the indigestible carbohydrates may be included without limitation as long as they contain cellulose and/or hemicellulose as an active ingredient. there is.
하기에 본 발명의 균주를 유효성분으로 포함하는 미생물 제제예를 설명하나, 본 발명은 이를 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.Hereinafter, examples of microbial preparations containing the strain of the present invention as an active ingredient will be described, but the present invention is not intended to limit them, but only to be specifically described.
제제예 1: 산제의 제조Formulation Example 1: Preparation of powder
본 발명에 따른 라크리미스포라 알지딕실라놀리티카 균주 (기탁번호 KCTC14734BP), 이의 세포 용해물, 배양액 또는 이들의 혼합물 20 mg, 유당수화물 100 mg 및 탈크 10 mg.20 mg of the Lacrymispora algidisilanolytica strain according to the present invention (Accession No. KCTC14734BP), its cell lysate, culture medium or a mixture thereof, 100 mg of lactose hydrate and 10 mg of talc.
상기의 성분들을 혼합하고 기밀포에 충진하여 산제를 제조하였다.A powder was prepared by mixing the above components and filling in airtight bags.
제제예 2: 정제의 제조Formulation Example 2: Preparation of tablets
본 발명에 따른 라크리미스포라 알지딕실라놀리티카 균주 (기탁번호 KCTC14734BP), 이의 세포 용해물, 배양액 또는 이들의 혼합물 10 mg, 옥수수전분 100 mg, 유당수화물 100 mg 및 스테아르산마그네슘 2 mg.10 mg of the Lacrymisspora algidisilanolytica strain according to the present invention (Accession No. KCTC14734BP), its cell lysate, culture medium or a mixture thereof, 100 mg of corn starch, 100 mg of lactose hydrate, and 2 mg of magnesium stearate.
상기의 성분을 혼합한 후, 통상의 정제의 제조방법에 따라서 타정하여 정제를 제조하였다.After mixing the above ingredients, tablets were prepared by tableting according to a conventional tablet manufacturing method.
제제예 3: 캅셀제의 제조Formulation Example 3: Preparation of capsule formulation
본 발명에 따른 라크리미스포라 알지딕실라놀리티카 균주 (기탁번호 KCTC14734BP), 이의 세포 용해물, 배양액 또는 이들의 혼합물 10 mg, 미결정셀룰로오스 3 mg, 유당수화물 14.8 mg 및 스테아르산마그네슘 0.2 mg.10 mg of the Lacrymispora algidisilanolytica strain according to the present invention (Accession No. KCTC14734BP), its cell lysate, culture medium or a mixture thereof, 3 mg of microcrystalline cellulose, 14.8 mg of lactose hydrate and 0.2 mg of magnesium stearate.
상기의 성분을 혼합한 후, 통상의 캅셀제의 제조방법에 따라서 젤라틴캡슐에 충전하여 캅셀제를 제조하였다.After mixing the above ingredients, capsules were prepared by filling gelatin capsules according to a conventional capsule preparation method.
제제예 4: 주사제의 제조Formulation Example 4: Preparation of injection
본 발명에 따른 라크리미스포라 알지딕실라놀리티카 균주 (기탁번호 KCTC14734BP), 이의 세포 용해물, 배양액 또는 이들의 혼합물 균주 10 mg, 만니톨 180 mg, 주사용 멸균 증류수 2974 mg 및 인산일수소나트륨 26 mg.10 mg of Lacrymisspora algidisilanolytica strain according to the present invention (Accession No. KCTC14734BP), its cell lysate, culture medium or a mixture thereof, 180 mg of mannitol, 2974 mg of sterile distilled water for injection and 26 sodium hydrogen phosphate mg.
상기의 성분을 혼합한 후, 통상의 주사제의 제조방법에 따라 1앰플 당(2 mL) 상기의 성분 함량으로 제조하였다.After mixing the above components, it was prepared with the above component content per 1 ampoule (2 mL) according to a conventional method for preparing injections.
제제예 5: 액제의 제조Formulation Example 5: Preparation of liquid formulation
본 발명에 따른 라크리미스포라 알지딕실라놀리티카 균주 (기탁번호 KCTC14734BP), 이의 세포 용해물, 배양액 또는 이들의 혼합물 10 mg, 이성화당 10 g, 만니톨 5 g, 정제수 적량 및 레몬향 적량.10 mg of the Lacrymisspora algidisilanolytica strain according to the present invention (Accession No. KCTC14734BP), its cell lysate, culture medium or a mixture thereof, 10 g of isomerized sugar, 5 g of mannitol, an appropriate amount of purified water and an appropriate amount of lemon flavor.
상기의 성분을 통상의 제조방법에 따라 정제수에 각각의 성분을 가하여 용해시키고 레몬향을 적량 가한 다음 정제수를 가하여 전체 100 mL로 조절한 후 멸균시켜 갈색병에 충진하여 액제를 제조한다. The above components are added to and dissolved in purified water according to a conventional manufacturing method, lemon flavor is added in an appropriate amount, purified water is added to adjust the total volume to 100 mL, and then sterilized and filled in a brown bottle to prepare a liquid formulation.
제제예 6: 건강기능식품의 제조Formulation Example 6: Manufacture of health functional food
본 발명에 따른 라크리미스포라 알지딕실라놀리티카 균주 (기탁번호 KCTC14734BP), 이의 세포 용해물, 배양액 또는 이들의 혼합물 10 mg, 비타민 혼합물 적량, 비타민 A 아세테이트 70 ㎍ 및 비타민 E 1.0 ㎎ 및 비타민 B1 0.13 ㎎.10 mg of the Lacrymispora algidisilanolytica strain according to the present invention (Accession No. KCTC14734BP), its cell lysate, culture medium or a mixture thereof, an appropriate amount of vitamin mixture, 70 μg of vitamin A acetate, 1.0 mg of vitamin E, and vitamin B1 0.13 mg.
제제예 7: 사료 첨가제 조성물의 제조Formulation Example 7: Preparation of feed additive composition
본 발명에 따른 라크리미스포라 알지딕실라놀리티카 균주 (기탁번호 KCTC14734BP), 이의 세포 용해물, 배양액 또는 이들의 혼합물 10 g, 비타민 B1 0.2 g, 비타민 B2 0.2 g, 비타민 D 0.2 g, 비타민 E 0.2 g, 비타민 P 0.2 g, 판토텐산 0.2 g, 아미노산 0.2 g, 콜린 0.2 g 및 부형제로서 글루코오즈 178.4 g을 혼합하여 본 발명의 사료 첨가제 조성물을 제조하였다.Lacrymispora algidisilanolytica strain according to the present invention (Accession No. KCTC14734BP), its cell lysate, culture medium or mixture thereof 10 g, vitamin B1 0.2 g, vitamin B2 0.2 g, vitamin D 0.2 g, vitamin E A feed additive composition of the present invention was prepared by mixing 0.2 g of vitamin P, 0.2 g of vitamin P, 0.2 g of pantothenic acid, 0.2 g of amino acid, 0.2 g of choline, and 178.4 g of glucose as an excipient.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail through examples. These examples are only for exemplifying the present invention, and it will be apparent to those skilled in the art that the scope of the present invention is not to be construed as being limited by these examples.
β-만나아제 생산 균주의 분리Isolation of β-mannanase producing strains
1-1. 한우의 장 유래 미생물 균주 분리1-1. Isolation of intestinal-derived microbial strains from Korean cattle
평창에 위치한 국립축산과학원 한우연구소 내 사육중에 있는 한우들로부터 채취한 각각의 분변 시료 중 1 g을 멸균 생리 식염수 (0.85% NaCl) 9 mL에 현탁시키고, 5%의 양 혈액 (sheep blood)이 포함된 TSA (Tryptic soy agar) 배지 (이하, TSA 혈액 배지)에 104 ~ 106으로 희석한 희석액 0.1 mL을 도말하여 37℃ 혐기성 배양기에서 48 시간 배양하였으며, 배양 후 해당 배지 표면에 증식한 독립된 단일 집락을 백금이로 다시 채취하여 혐기적 조건하에서 같은 배지에 재접종과 배양하는 과정을 수차례 실시하여 순수하게 분리된 균주 100종 이상을 확보하였다.1 g of each fecal sample collected from Korean cattle under breeding in the Korean Cattle Research Institute of the National Institute of Animal Science and Technology located in Pyeongchang was suspended in 9 mL of sterile physiological saline (0.85% NaCl), containing 5% sheep blood. TSA (Tryptic soy agar) medium (hereinafter referred to as TSA blood medium) was smeared with 0.1 mL of the diluted solution diluted with 10 4 to 10 6 and cultured in an anaerobic incubator at 37 ° C for 48 hours. Colonies were re-collected with Platinum, and the process of re-inoculation and culturing in the same medium under anaerobic conditions was performed several times to secure more than 100 strains that were purely isolated.
1-2. β-만나아제 효소 생산 장 유래 미생물 후보 균주 발굴을 위한 대상 효소 기질 로커스트 빈 검 (LBG) 이용 겔 확산 검정 분석 조건 확립1-2. Establishment of gel diffusion assay analysis conditions using locust bean gum (LBG) as a target enzyme substrate for discovery of β-mannanase enzyme-producing gut-derived microbial candidate strains
한우 분변으로부터 분리된 100종 이상의 장내 미생물의 β-만나아제 활성유무 확인을 위하여, β-만나아제 효소에 대한 대상 기질로 활용되는 LBG를 0.25%되게 첨가된 멸균 TSA 배지를 제조한 후, 여기에 상업적으로 판매되는 헬릭스 포마티아 (Helix pomatia) 유래 β-만나아제 (Sigma-Aldrich, M9400) 효소를 멸균 인산완충생리식염수 (PBS; Phosphate buffered saline) 용액에 2, 5 및 10 mU 활성 단위로 희석하여 5 μL 씩 48 시간 접종 및 배양하였으며, 배양 종료 시점에 Congo red 염색법을 이용하여 나타나는 투명한 환의 크기에 따라 겔 확산 분석 조건을 확립하였다 [도 1].In order to confirm the presence or absence of β-mannanase activity of more than 100 species of intestinal microorganisms isolated from Korean cow feces, a sterile TSA medium containing 0.25% of LBG, which is used as a target substrate for β-mannanase enzyme, was prepared, and then, Commercially sold Helix pomatia ( Helix pomatia ) Derived β- metase (Sigma-Aldrich, M9400) enzyme is diluted in sterile phosphate buffered saline (PBS; Phosphate buffered saline) solution in 2, 5 and 10 mU
1-3. 한우 장 유래 미생물 균주 세포 용해물을 이용한 β-만나아제 효소 생산 균주 선별1-3. Selection of strains producing β-mannase enzyme using microbial strain cell lysate derived from Korean cattle
앞서 확립된 LBG 함유 TSA 배지 분석 조건를 이용하여 β-만나아제 효소를 생산하는 한우의 장 유래 미생물 후보 균주를 발굴하고자, 확보된 100종 이상의 균주 각각을 TSA 혈액 배지에 도말하여 37℃에서 24 시간 혐기적 배양을 하였다. 이어 미생물 균주의 세포 용해물을 제조하기 위하여, 도말되어 증식된 각각의 미생물 콜로니들은 균주별로 모아 PBS 용액에 현탁시키고 bead ruptor (직경 0.2 mm 유리 비드 포함)에서 5 분간 파쇄를 실시하였으며, 10000 rpm에서 15 분간 원심분리하여 얻어진 상층액을 멸균 여과 필터 (pore size 0.2 μm)로 여과하여 준비하였다. 얻어진 균주별 세포 용해물은 단백질 농도가 200 μg/mL이 되도록 희석한 후, 이중 25 μL (단백질 농도 기준 5 μg)를 LBG 기질이 포함된 TSA 배지에 세번에 나누어 접종하고 37℃에서 48 시간 배양 및 Congo red 염색을 통해 β-만나아제 효소 활성 존재 유무를 평가하였다. 실험 결과, 표 1에 나타낸 바와 같이 100종 이상의 소의 장 유래 미생물로부터 1종의 균주가 β-만나아제 효소 활성을 지니고 있음이 확인되었다.In order to discover candidate strains of microorganisms derived from the intestines of Korean cattle that produce β-mannase enzymes using the previously established LBG-containing TSA medium analysis conditions, each of the obtained strains of more than 100 species was smeared on TSA blood medium and incubated at 37 ° C for 24 hours. miracle culture was performed. Then, in order to prepare cell lysates of microbial strains, each of the microbial colonies that were plated and proliferated was collected by strain, suspended in a PBS solution, and disrupted in a bead ruptor (including glass beads with a diameter of 0.2 mm) for 5 minutes, at 10000 rpm. The supernatant obtained by centrifugation for 15 minutes was prepared by filtering through a sterile filtration filter (pore size 0.2 μm). After diluting the obtained cell lysate for each strain to a protein concentration of 200 μg/mL, 25 μL (5 μg based on protein concentration) was inoculated in three times in TSA medium containing LBG substrate and incubated at 37°C for 48 hours. And the presence or absence of β-mannase enzyme activity was evaluated through Congo red staining. As a result of the experiment, as shown in Table 1, it was confirmed that one strain from more than 100 kinds of bovine intestine-derived microorganisms had β-mannase enzyme activity.
β-만나아제 생산 후보 CM01 균주의 탄수화물 기질별 분해 활성 평가Evaluation of degradation activity by carbohydrate substrate of β-mannanase production candidate CM01 strain
선별된 β-만나아제 활성 보유 한우 장 유래 미생물 후보 균주 CM01의 해당 분해 활성 이외에도 다른 탄수화물에 대한 분해능을 가지는지 살펴보기 위하여, 기질로서 1%의 전분, 0.2%의 CM-셀룰로오스, 0.02%의 X-gal (5-브로모-4-클로로-3-인돌일-β-갈락토피라노사이드)이 포함된 각각의 TSA 배지를 제조하고 여기에 β-만나아제 생산 후보 균주 CM01의 세포 용해물 5 μg을 접종하고 혐기적 조건하에서 48 시간 배양하였다. 배양의 종료시점에 이르러 CM01 균주의 전분 분해 활성 평가는 Gram's iodine 염색법을, 그리고 CM-셀룰로오스 분해 활성 평가는 Congo red 염색법을 이용하여 나타나는 투명한 환의 존재 유무로 판단하였고, X-gal의 분해 활성 평가는 해당 기질이 초록색 환이 생성되는 것으로 판단하였다. 실험의 검증을 위한 대조구로는 앞서의 도 1의 실험에서처럼 0.25% LBG 함유 TSA 배지를 이용하였다. 실험 결과, 도 2에 제시한 것과 같이 CM01 균주는 결과와 동일한 β-만나아제 활성을 보유하고 있음을 재검증할 수 있었으며, 동시에 강력한 CM-셀룰로오스 분해 활성도 지니고 있어 해당 후보 균주는 적어도 β-만나아제 및 셀룰라아제 효소 2종을 생산하는 것으로 추정되었다. 한편, 전분과 X-gal 분해 활성은 현재의 조건 (세포 용해물 또는 그 접종농도 등)하에서는 관찰되지 않았다.In order to examine whether CM01, a candidate strain of Korean beef intestine-derived microorganisms with β-mannase activity, has degrading ability for other carbohydrates in addition to the glycolytic activity, 1% starch, 0.2% CM-cellulose, and 0.02% X as substrates. Each TSA medium containing -gal (5-bromo-4-chloro-3-indolyl-β-galactopyranoside) was prepared, and
셀룰라아제 및 β-만나아제 효소 생산 CM01 균주의 동정Identification of CM01 strains producing cellulase and β-mannase enzymes
셀룰라아제 및 β-만나아제 효소를 생산하는 것으로 확인된 한우의 장 유래 미생물 후보 균주 CM01의 균주 동정을 위하여, 해당 미생물의 16S RNA 유전자 분석을 염기서열 전문 분석업체인 ㈜마크로젠에 의뢰하였다. 그 결과, 표 2에 나타낸 바와 같이 해당 CM01 균주는 100%의 상동성으로 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica)인 것으로 동정되었다.In order to identify the strain of CM01, a candidate strain of Korean cattle gut-derived microorganisms confirmed to produce cellulase and β-mannase enzymes, 16S RNA gene analysis of the microorganism was requested from Macrogen, a professional sequencing company. As a result, as shown in Table 2, the CM01 strain was identified as Lacrimispora algidixylanolytica with 100% homology.
(이명: Clostridium algidixylanolyticum)(Synonym: Clostridium algidixylanolyticum)
AGAGCTTTTGCTTCCCCAACACCTAGTATTCATCGTTTACGGCGTGGACTACC
AGGGTATCTAATCCTGTTTGCTCCCCACGCTTTCGAGCCTCAACGTCAGTTAC
AGTCCAGTAAGCCGCCTTCGCCACTGGTGTTCCTCCTAATATCTACGCATTTC
ACCGCTACACTAGGAATTCCACTTACCTCTCCTGCACTCTAGCTCCACAGTTT
CCAAAGCAGTCCCGGGGTTGAGCCCCGGGCTTTCACTCCAGACTTGCAGAGCC
GTCTACGCTCCCTTTACACCCAGTAAATCCGGATAACGCTTGCCCCCTACGTA
TTACCGCGGCTGCTGGCACGTAGTTAGCCGGGGCTTCTTAGTCAGGTACCGTC
ATTTTCTTCCCTGCTGATAGACCTTTACATACCGAAATACTTCTTCAGTCACG
CGGCGTCGCTGGATCAGGGTTTCCCCCATTGTCCAATATTCCCCACTGCTGCC
TCCCGTAGGAGTTTGGGCCGTGTCTCAGTCCCAATGTGGCCGGTCACCCTCTC
AGGTCGGCTACTGATCGTCGGCTTGGTGGGCCGTTACCTCACCAACTACCTAA
TCAGACGCGGGTCCATCTCATACCACCGGAGTTTTTCACACTGTGCTATGCAG
CACTGTGCGCTTATGCGGTATTAGCAGTCATTTCTAACTGTTATCCCCCTGTA
TGAGGCAGGTTACCCACGCGTTACTCACCCGTCCGCCGCTAAGTCAATTTTAA
TTCCACCCGAAGGCTTCCTTAAAATCGCTTCGCTCGACTTGCATGTGTTAAGC
ACGCCGCCAGCGTTCATCTGACGGAGGAAGAAACCTTAAAAAAAAAAAACCAA
CGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG
GGGGGGGGGGGGGGGGGGCGGGGGGGGGGGGGGGGGGGGGGGGCGGGGGCCCC
CCCCGCGGGGGGGGGGGGGGCCGTCCCCCCCCCCGCCCCCGCGGGGGGGGGGG
GGGCCCCCCCCCCCCGCCGCGCCCGGGGGTTCTTTTTT (서열번호 1)TCTTGCTAAGTCTCCCAGGTGGATTACTTTATTGCGTTAGCGACGGCACCGA
AGAGCTTTTGCTTCCCCAACACCTAGTATTCATCGTTTACGGCGTGGACTACC
AGGGTATCTAATCCTGTTTGCTCCCCACGCTTTCGAGCCTCAACGTCAGTTAC
AGTCCAGTAAGCCGCCTTCGCCACTGGTGTTCCTCCTAATATCTACGCATTTC
ACCGCTACACTAGGAATTCCACTTACCTCTCCTGCACTCTAGCTCCACAGTTT
CCAAAGCAGTCCCGGGGTTGAGCCCCGGGCTTTCACTCCAGACTTGCAGAGCC
GTCTACGCTCCCTTTACACCCAGTAAATCCGGATAACGCTTGCCCCCTACGTA
TTACCGCGGCTGCTGGCACGTAGTTAGCCGGGGCTTCTTAGTCAGGTACCGTC
ATTTTCTTCCCTGCTGATAGACCTTTACATACCGAAATACTTCTTCAGTCACG
CGGCGTCGCTGGATCAGGGTTTCCCCCATTGTCCAATATTCCCCACTGCTGCC
TCCCGTAGGAGTTTTGGGCCGTGTCTCAGTCCCAATGTGGCCGGTCACCCTCTC
AGGTCGGCTACTGATCGTCGGCTTGGTGGGCCGTTACCTCACCAACTACCTAA
TCAGACGCGGGTCCATCTCATACCACCGGAGTTTTTCACACTGTGCTATGCAG
CACTGTGCGCTTATGCGGTATTAGCAGTCATTTCTAACTGTTATCCCCCTGTA
TGAGGCAGGTTACCCACGCGTTACTCACCCGTCCGCCGCTAAGTCAATTTTAA
TTCCACCCGAAGGCTTCCTTAAAATCGCTTCGCTCGACTTGCATGTGTTAAGC
ACGCCGCCAGCGTTCATCTGACGGAGGAAGAAACCTTAAAAAAAAAAAACCAA
CGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG
GGGGGGGGGGGGGGGGGGCGGGGGGGGGGGGGGGGGGGGGGGGGCGGGGGCCCC
CCCCGCGGGGGGGGGGGGGGCCGTCCCCCCCCCCGCCCCCGCGGGGGGGGGGGG
GGGCCCCCCCCCCCCGCCGCGCCCGGGGGTTCTTTTTT (SEQ ID NO: 1)
라크리미스포라 알지딕실라놀리티카 (Lacrymisspora Algidixylanolytica ( Lacrimispora algidixylanolyticaLacrimispora algidixylanolytica ) CM01 균주의 생균 및 배양액의 탄수화물 기질별 분해 활성 평가) Evaluation of decomposition activity by carbohydrate substrate of live cells and culture medium of strain CM01
한우의 장 유래 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) CM01 균주의 세포 용해물이 가지는 CM-셀룰로오스 및 LBG와 같은 2종의 탄수화물 기질들에 대한 분해 활성이 해당 균주의 생균 및 배양액에서도 재현되는지를 확인하기 위하여, CM01 균주를 TSA 혈액 배지에 도말하여 단일 콜로니 배양을 실시한 다음 단일 집락 하나를 10 mL의 TS 배양액 (Tryptic soy broth)에 접종하여 37℃에서 혐기적인 조건하에서 24 시간 배양하였다. 이후 4000 rpm에서 20 분간 원심분리하여 생균과 배양액을 분리하였다. CM01 생균의 경우, 동일 원심분리 조건에서 1 mL PBS 용액으로 2번 세척을 실시한 후에 최종적으로 같은 용량의 PBS 용액에 현탁하여 이중 10 μL를 앞서 수행한 CM01 균주 세포 용해물 실험에 이용하였던 동일한 1% 전분, 0.2% CM-셀룰로오스, 0.02% X-gal 및 0.25% LBG가 함유된 각각의 TSA 배지에 접종하여 혐기적 조건하에서 48 시간 배양을 통해 탄수화물 기질별 분해 활성 정도를 평가하였다. CM01 균주 배양액의 경우에는 멸균 여과 필터 (pore size 0.2 μm)로 여과한 후에 냉동하고 동결건조기를 이용하여 수분을 완전히 제거한 다음 여기에 멸균 증류수 2 mL을 첨가하여 5배 농축하였다. 제조된 5배 농축 BG03 균주 배양액은 생균 접종 시에 이용된 동일한 4종의 기질별 TSA 배지들에 각각 25 μL씩 4번 총 100 μL 접종하여 혐기적 조건하에서 48시간 배양에 따른 활성 평가를 실시하였다. 그 결과, 도 3에 나타낸 바와 같이 앞서의 세포 용해물 실험 결과와는 다르게 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) CM01 균주는 CM-셀룰로오스 및 LBG에 대한 강력한 분해 활성 뿐만아니라 전분에 대해서도 강력한 분해 활성을 나타내었으며, X-gal 분해 활성도 미약하게 가지고 있는 것으로 관찰되었다. 이러한 결과로 볼때, 적어도 CM01 균주 생균은 상당한 양의 아밀라아제, 셀룰라아제 및 β-만나아제와 같은 3종의 탄수화물 분해 효소들을 생산하고 있다는 것을 의미하였다. 또한 CM01 균주 배양액도 도 4에 제시한 것처럼, 생균과 매우 유사한 전분, CM-셀룰로오스 및 LBG 기질의 분해 활성을 나타내어, 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) CM01 균주는 이들 3종의 탄수화물 분해 효소들을 세포 외부로 분비하고 있음을 추정케 하였다. 한편, CM01 균주의 배양액은 X-gal을 분해하지 못하였기 때문에 β-갈락토시다아제 효소 생산에 있어서 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) CM01 균주의 역할은 상당히 제한적일 것으로 판단되였다.The degrading activity of the cell lysate of the Korean cattle intestine-derived Lacrimispora algidixylanolytica CM01 strain on two carbohydrate substrates, such as CM-cellulose and LBG, was also found in the live cells and culture medium of the strain. In order to confirm that it reproduces, the CM01 strain was smeared on TSA blood medium to perform single colony culture, and then a single colony was inoculated into 10 mL of TS culture medium (Tryptic soy broth) and cultured for 24 hours under anaerobic conditions at 37 ° C. . Thereafter, viable cells and culture medium were separated by centrifugation at 4000 rpm for 20 minutes. In the case of CM01 viable cells, after washing twice with a 1 mL PBS solution under the same centrifugation conditions, they were finally suspended in the same volume of PBS solution, and 10 μL of this was the same 1% used in the previous CM01 strain cell lysate experiment. Each TSA medium containing starch, 0.2% CM-cellulose, 0.02% X-gal, and 0.25% LBG was inoculated and cultured for 48 hours under anaerobic conditions to evaluate the degree of decomposition activity for each carbohydrate substrate. In the case of the CM01 strain culture solution, after filtering with a sterile filtration filter (pore size 0.2 μm), it was frozen, water was completely removed using a lyophilizer, and 2 mL of sterile distilled water was added thereto to concentrate 5 times. The prepared 5-fold concentrated BG03 strain culture solution was inoculated in a total of 100 μL of 25 μL each 4 times in the same 4 types of TSA media for each substrate used for live cell inoculation, and the activity was evaluated by culturing for 48 hours under anaerobic conditions. . As a result, as shown in FIG. 3, unlike the previous cell lysate test results, the Lacrimispora algidixylanolytica CM01 strain had strong degradation activity for CM-cellulose and LBG as well as for starch. It showed strong decomposition activity, and it was observed that X-gal decomposition activity was also weak. In view of these results, at least the live bacteria of the CM01 strain indicated that significant amounts of amylase, cellulase, and β-mannanase were producing three types of carbohydrate degrading enzymes. In addition, as shown in FIG. 4, the CM01 strain culture medium also exhibits decomposition activities of starch, CM-cellulose, and LBG substrates very similar to live bacteria, so that Lacrimispora algidixylanolytica CM01 strain is It was assumed that carbohydrate decomposition enzymes were secreted outside the cell. On the other hand, since the culture medium of the CM01 strain did not degrade X-gal, the role of the Lacrimispora algidixylanolytica CM01 strain in the production of β-galactosidase enzyme was considered to be quite limited.
생균 및 배양액의 탄수화물 기질별 분해 활성 평가를 통해 아밀라아제, 셀룰라아제 및 β-만나아제와 같은 3종의 탄수화물 분해 효소들을 생산 및 분비하는 것으로 확인된 라크리미스포라 알지딕실라놀리티카 (Lacrimispora algidixylanolytica) CM01 균주는 한국생명공학연구원에 기탁하여 아래와 같이 기탁번호를 부여받았다. Lacrimispora algidixylanolytica CM01 confirmed to produce and secrete three types of carbohydrate-degrading enzymes, such as amylase, cellulase and β-mannase, through evaluation of the degradation activity of live cells and culture medium for each carbohydrate substrate The strain was deposited with the Korea Research Institute of Bioscience and Biotechnology and was assigned an accession number as follows.
SEQUENCE LISTING <110> Korea Atomic Energy Research Institute <120> Novel strain of Lacrimispora algidixylanolytica producing carbohydrase and use thereof <130> 1069327 <160> 1 <170> PatentIn version 3.2 <210> 1 <211> 1098 <212> DNA <213> Artificial <220> <223> Lacrimispora algidixylanolytica (Clostridium algidixylanolyticum) 16S RNA <400> 1 tcttggctaa gtctcccagg tggattactt tattgcgtta gcgacggcac cgaagagctt 60 ttgcttcccc aacacctagt attcatcgtt tacggcgtgg actaccaggg tatctaatcc 120 tgtttgctcc ccacgctttc gagcctcaac gtcagttaca gtccagtaag ccgccttcgc 180 cactggtgtt cctcctaata tctacgcatt tcaccgctac actaggaatt ccacttacct 240 ctcctgcact ctagctccac agtttccaaa gcagtcccgg ggttgagccc cgggctttca 300 ctccagactt gcagagccgt ctacgctccc tttacaccca gtaaatccgg ataacgcttg 360 ccccctacgt attaccgcgg ctgctggcac gtagttagcc ggggcttctt agtcaggtac 420 cgtcattttc ttccctgctg atagaccttt acataccgaa atacttcttc agtcacgcgg 480 cgtcgctgga tcagggtttc ccccattgtc caatattccc cactgctgcc tcccgtagga 540 gtttgggccg tgtctcagtc ccaatgtggc cggtcaccct ctcaggtcgg ctactgatcg 600 tcggcttggt gggccgttac ctcaccaact acctaatcag acgcgggtcc atctcatacc 660 accggagttt ttcacactgt gctatgcagc actgtgcgct tatgcggtat tagcagtcat 720 ttctaactgt tatccccctg tatgaggcag gttacccacg cgttactcac ccgtccgccg 780 ctaagtcaat tttaattcca cccgaaggct tccttaaaat cgcttcgctc gacttgcatg 840 tgttaagcac gccgccagcg ttcatctgac ggaggaagaa accttaaaaa aaaaaaacca 900 acgggggggg gggggggggg gggggggggg gggggggggg gggggggggg gggggggggg 960 gggggggggg ggcggggggg gggggggggg gggggggcgg gggccccccc cgcggggggg 1020 gggggggccg tccccccccc cgcccccgcg gggggggggg gggccccccc cccccgccgc 1080 gcccgggggt tctttttt 1098 SEQUENCE LISTING <110> Korea Atomic Energy Research Institute <120> Novel strain of Lacrimispora algidixylanolytica producing carbohydrase and its use <130> 1069327 <160> 1 <170> PatentIn version 3.2 <210> 1 <211> 1098 <212> DNA <213> artificial <220> <223> Lacrimispora algidixylanolytica (Clostridium algidixylanolyticum) 16S RNA <400> 1 tcttggctaa gtctcccagg tggattactt tattgcgtta gcgacggcac cgaagagctt 60 ttgcttcccc aacacctagt attcatcgtt tacggcgtgg actaccaggg tatctaatcc 120 tgtttgctcc ccacgctttc gagcctcaac gtcagttaca gtccagtaag ccgccttcgc 180 cactggtgtt cctcctaata tctacgcatt tcaccgctac actaggaatt ccacttacct 240 ctcctgcact ctagctccac agtttccaaa gcagtcccgg ggttgagccc cgggctttca 300 ctccagactt gcagagccgt ctacgctccc tttacaccca gtaaatccgg ataacgcttg 360 ccccctacgt attaccgcgg ctgctggcac gtagttagcc ggggcttctt agtcaggtac 420 cgtcattttc ttccctgctg atagaccttt acataccgaa atacttcttc agtcacgcgg 480 cgtcgctgga tcagggtttc ccccattgtc caatattccc cactgctgcc tcccgtagga 540 gtttgggccg tgtctcagtc ccaatgtggc cggtcaccct ctcaggtcgg ctactgatcg 600 tcggcttggt gggccgttac ctcaccaact acctaatcag acgcgggtcc atctcatacc 660 accggagttt ttcacactgt gctatgcagc actgtgcgct tatgcggtat tagcagtcat 720 ttctaactgt tatccccctg tatgaggcag gttacccacg cgttactcac ccgtccgccg 780 ctaagtcaat tttaattcca cccgaaggct tccttaaaat cgcttcgctc gacttgcatg 840 tgttaagcac gccgccagcg ttcatctgac ggaggaagaa accttaaaaa aaaaaaacca 900 acgggggggg gggggggggg gggggggggg gggggggggg gggggggggg gggggggggg 960 gggggggggg ggcggggggg gggggggggg gggggggcgg gggccccccc cgcggggggg 1020 gggggggccg tccccccccc cgcccccgcg gggggggggg gggccccccc cccccgccgc 1080 gcccgggggt tctttttt 1098
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210147370A KR20230062278A (en) | 2021-10-29 | 2021-10-29 | Novel strain of Lacrimispora algidixylanolytica producing carbohydrase and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210147370A KR20230062278A (en) | 2021-10-29 | 2021-10-29 | Novel strain of Lacrimispora algidixylanolytica producing carbohydrase and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230062278A true KR20230062278A (en) | 2023-05-09 |
Family
ID=86408734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210147370A KR20230062278A (en) | 2021-10-29 | 2021-10-29 | Novel strain of Lacrimispora algidixylanolytica producing carbohydrase and use thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230062278A (en) |
-
2021
- 2021-10-29 KR KR1020210147370A patent/KR20230062278A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5872104B2 (en) | New Bacillus subtilis {NOVELBACILLUSSUBTILIS} | |
CN1283172C (en) | Two-effects microbiological additives of forage specially used for ruminants | |
JP5728185B2 (en) | Method for producing fermented soybean meal using Bacillus subtilis | |
US11607434B2 (en) | Bacillus compositions and methods of use with ruminants | |
CN105851492A (en) | Traditional Chinese medicine probiotic fermented feed and preparation method | |
CN110122658A (en) | A kind of fermentative feedstuff of microbe and its preparation method and application | |
CN109362987B (en) | Poultry antibiotic-free mulberry leaf fermentation concentrated material and preparation method thereof | |
CN103005159A (en) | Preparation method of ginkgo leaf biological feed additive | |
CN113498433A (en) | Composition for preventing, improving or treating obesity or fatty liver disease comprising leuconostoc citreum WIKIM0104 | |
CN111011643A (en) | Bacterium enzyme fermented traditional Chinese medicine for improving growth performance of broiler chicken and preparation method thereof | |
CN109007370A (en) | Complex function additive for feed for piglets and preparation method thereof | |
CN110521785A (en) | Probiotics fermention functional food and its preparation | |
WO2007034627A1 (en) | Additive for animal feed | |
KR101168658B1 (en) | Probiotics and fermenting livestock feed with probiotics and by-product of agricultual product | |
CN101999556B (en) | Special animal nutrient for beef cattle and preparation method thereof | |
KR101702499B1 (en) | Composition of formulated diets comprising novel lactic acid bacteria, fungus and bacterium | |
KR20210067850A (en) | Feed additive for preventing diarrhea of calf comprising mixture of Bacillus subtilis, saccharide and mineral as effective component and uses thereof | |
KR102130646B1 (en) | Novel lactobacillus salivarius and feed additives for aquacultural fish and crustacea comprising the same | |
JP2008048683A (en) | Viable bacteria agent for animal, feed composition, and method for using the agent and the composition | |
KR102131882B1 (en) | Method for preparing fermented composition with improved odor using yeast | |
CN101999554A (en) | Special animal nutrient for milk cows and preparation method thereof | |
KR102611484B1 (en) | Multi-functional probiotics for marine fish and uses thereof | |
CN110545672A (en) | Method for producing fermented guar flour | |
CN102106487B (en) | Biological fermentation feed for laying chickens and production method | |
KR20230062278A (en) | Novel strain of Lacrimispora algidixylanolytica producing carbohydrase and use thereof |